Drug discovery companies identify, validate and develop new therapeutic candidates for the prevention and treatment of disease. The sector combines biology, chemistry, data science and clinical expertise to bring new medicines from concept to clinic.
This category includes companies working on:
Browse 422 UK drug discovery companies below.
Recombinant proteins, antibodies and reagents for drug development
ACROBiosystems is a global supplier of recombinant proteins, antibodies, kits and GMP-grade reagents supporting biopharmaceutical research and development. Products are used…
DNA topoisomerase enzymes and substrates for drug discovery
Inspiralis is a John Innes Centre spinout supplying DNA-modifying enzymes, substrates and assay kits to pharmaceutical and academic researchers. Its product range centres on…
DNA damage response platform targeting hard-to-treat solid tumours
Artios Pharma is a clinical-stage biopharmaceutical company developing small molecule therapeutics that target DNA damage response pathways in cancer cells. The company's pipeline…
Global biopharma with UK R&D centre on the Wirral Peninsula
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company with a long-established UK R&D site at Moreton on the Wirral Peninsula and its UK and Ireland commercial…
Engineered hybrid interferon therapeutics for viral and immune-mediated disease
ILC Therapeutics is a pre-clinical biotechnology company developing hybrid interferons, an engineered cytokine drug class combining favourable attributes of multiple naturally…
AI platform designing vaccines against current and future pathogens
Baseimmune is a biotechnology company developing a deep learning platform for computational vaccine antigen design. The platform integrates genomic, epidemiological,…
Clinical-stage rare disease biotech acquiring deprioritised pharma assets
Mereo BioPharma is a clinical-stage biopharmaceutical company focused on developing treatments for rare diseases. Founded in 2015, its business model centres on acquiring…
Preclinical CRO for pharmaceutical and agrochemical drug development
Labcorp Early Development Laboratories is a major nonclinical contract research organisation operating from its Harrogate campus in North Yorkshire. The facility provides…
No-code digital experiment platform for life science R&D
Synthace provides cloud-based software that enables life science researchers to design, automate and analyse experiments without writing code. Its platform integrates with…
Small molecule protein degraders targeting oncology and CNS disease
Kesmalea Therapeutics is a biotechnology company developing oral small molecule therapeutics that modulate protein homeostasis through targeted protein degradation and…
Proprietary phage display platform for therapeutic antibody discovery
RxBiologics is a Cambridge-based antibody discovery CRO and subsidiary of RxCelerate. Its proprietary phage display library platform incorporates in-line optimisation technology…
Bioanalytical and toxicology laboratory for pharmaceutical and clinical research
Analytical Services International is a GLP and GCP-compliant bioanalytical laboratory providing mass spectrometry-based services to pharmaceutical companies and contract research…